NCT07443475 2026-03-02
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
Phase 2 Recruiting
Clinical Trials
16 trialsNCT06388252 2026-02-19
Electrochemotherapy Changes in Tumor Microenvironment of Cutaneous and Subcutaneous Metastases in Melanoma Patients
Institute of Oncology Ljubljana
Phase NA Enrolling by invitation
NCT07404605 2026-02-19
Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma
Institute of Oncology Ljubljana
Phase NA Recruiting
NCT06660121 2025-12-23
ECT-DESMO
Istituto Ortopedico Rizzoli
Recruiting
NCT06709937 2024-11-29
GISEL
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT04760327 2024-10-17
GynECT
Institute of Oncology Ljubljana
Phase 2 Recruiting
NCT03448666 2024-09-23
ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases
European Institute of Oncology
Phase 2 Withdrawn
NCT05916690 2024-01-19
Electrochemotherapy for the Treatment of Vulvar Cancer
Institute of Oncology Ljubljana
Phase NA Unknown
NCT02352259 2021-03-24
Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II
Institute of Oncology Ljubljana
Phase 2 Completed
NCT01264952 2020-11-24
ECTJ
Institute of Oncology Ljubljana
Phase 1/2 Completed
NCT03040180 2019-01-25
nECT
Zealand University Hospital
Phase 2 Unknown
NCT03225781 2018-12-26
Electrochemoterapy With Bleomycin for the Treatment of Unresectable Pancreatic Cancer
Universita di Verona
Phase NA Terminated
NCT02549742 2017-01-18
Electrochemotherapy on Head and Neck Cancer
Rigshospitalet, Denmark
Phase 2 Unknown
NCT01479946 2014-12-09
Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin
Uppsala University Hospital
Phase 2 Withdrawn
NCT00744653 2014-07-18
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.
Copenhagen University Hospital at Herlev
Phase 2 Terminated
NCT00918593 2011-09-27
Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy
Copenhagen University Hospital at Herlev
Phase 2 Withdrawn